SHELLY SHIELDS: Open Payments
NPI 1497297824 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 13 payments from 5 companies in 2025. Trend: 2023 $486 · 2024 $511 · 2025 $661
Food & beverage: $653Education: $8
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $242 |
| Supernus Pharmaceuticals, Inc. | 8 | $185 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $89 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: Auvelity, Qelbree, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across IN — which companies pay providers there.
